Chromosomal aberrations and prognosis in patients with concomitant chemoradiotherapy for resected head and neck cancer

  • Authors:
    • Sung‑Won Park
    • Young‑Hoon Joo
    • Seung‑Hyun Jung
    • Seon‑Hee Yim
    • In‑Chul Nam
    • Kwang‑Jae Cho
    • Min‑Sik Kim
    • Yeun‑Jun Chung
  • View Affiliations

  • Published online on: January 26, 2016     https://doi.org/10.3892/or.2016.4595
  • Pages: 2207-2215
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Although concomitant chemoradiotherapy (CCRT) has recently become a mainstay of a primary treatment modality in advanced head and neck squamous cell carcinoma (HNSCC), some of the patients experience CCRT failure. If we can predict the CCRT outcomes, we can reduce unnecessary CCRT avoiding risk of CCRT‑related complication. We aimed to identify genetic alteration markers related to treatment failure in HNSCC patients who underwent radical surgery and CCRT. Genome‑wide copy number alterations (CNAs) were analyzed in 18 HNSCC patients with (n=9) or without (n=9) recurrence using oligoarray‑comparative genomic hybridization and candidate CNAs were validated by quantitative RT‑PCR. A total of 15 recurrently altered regions (RARs) were identified in the 18 HNSCC cases. Among them, two RARs were significantly associated with CCRT‑failure: copy number gained RARs of 7p11.2 harboring EGFR (P=0.029) and 18p11.32 harboring TYMS gene (P=0.029). Three RARs (7p11.2, 9p21.3 and 18p11.32) were significantly associated with poor disease‑specific survival in univariate analysis, and 7p11.2 was consistently significant in the multivariate analysis (HR 40.68, P=0.003). In conclusion, we defined novel genomic alterations associated with CCRT‑failure: 7p11.2 (EGFR) and 18p11.32 (TYMS). Our results provide useful clues for the elucidation of the molecular pathogenesis of HNSCC and to predict CCRT‑failure.
View Figures
View References

Related Articles

Journal Cover

April-2016
Volume 35 Issue 4

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Park SW, Joo YH, Jung SH, Yim SH, Nam IC, Cho KJ, Kim MS and Chung YJ: Chromosomal aberrations and prognosis in patients with concomitant chemoradiotherapy for resected head and neck cancer. Oncol Rep 35: 2207-2215, 2016
APA
Park, S., Joo, Y., Jung, S., Yim, S., Nam, I., Cho, K. ... Chung, Y. (2016). Chromosomal aberrations and prognosis in patients with concomitant chemoradiotherapy for resected head and neck cancer. Oncology Reports, 35, 2207-2215. https://doi.org/10.3892/or.2016.4595
MLA
Park, S., Joo, Y., Jung, S., Yim, S., Nam, I., Cho, K., Kim, M., Chung, Y."Chromosomal aberrations and prognosis in patients with concomitant chemoradiotherapy for resected head and neck cancer". Oncology Reports 35.4 (2016): 2207-2215.
Chicago
Park, S., Joo, Y., Jung, S., Yim, S., Nam, I., Cho, K., Kim, M., Chung, Y."Chromosomal aberrations and prognosis in patients with concomitant chemoradiotherapy for resected head and neck cancer". Oncology Reports 35, no. 4 (2016): 2207-2215. https://doi.org/10.3892/or.2016.4595